Job offersmore »

Tweeting Growers

Top 5 - yesterday

  • No news has been published yesterday.

Top 5 - last week

Top 5 - last month

Exchange ratesmore »

Two Biotechnology Manufacturing Experts Join Inocucor Advisory Board

Inocucor, the agri-tech company that produces biological crop inputs for row crops and high-value produce, has added two agriculture bioscience leaders, Carole Cobb and Gregg Bogosian, Ph.D., to its Manufacturing Advisory Board. 

Under the direction of Board Chair Jeff Lievense, Ph.D., one of the world's leading experts on fermentation process engineering, the independent advisory team will assist in the design of Inocucor's new production facility at its 30,000-square-foot U.S. headquarters and commercialization office in Centennial, Colo. It also will offer expertise as Inocucor scales up its process development and pilot manufacturing capabilities at the company’s Technical Center of Excellence, a 20,000-square-foot facility in Montreal.

Cobb is COO of GreenLight BioSciences and has over 30 years' experience in industrial biotechnology, worldwide manufacturing, technology acquisition, global supply chain and start-ups. She has overseen numerous fermentation-based manufacturing plants in the U.S., Europe, China and South America, as well as three major warehouse/distribution centers. She holds an MBA in Finance from the University of Rochester and a B.S. in Chemical Engineering, Biochemistry, and Cell and Molecular Biology from the State University of New York at Buffalo.

Bogosian is a consultant with more than 35 years' experience in biotechnology, specializing in the use of fermentation to produce microbial products. He is experienced in cGMP-compliant manufacturing of biologicals. Bogosian holds a Ph.D. in Biochemistry from Purdue University and has completed postdoctoral studies in Microbiology at the University of North Carolina at Chapel Hill. He earned a B.A. in Zoology at Miami University.

Inocucor uses a patented fermentation process to combine multi-strains of bacteria and yeasts into powerful soil and plant optimizers that are safe for people and the environment. These products naturally improve crop yields, shorten growing periods and create healthier, more resilient soils for farmers and greenhouse growers.

Inocucor recently completed the $38.8 million CAD ($29 million USD) first close of its Series B financing round, with lead investor TPG Alternative and Renewable Technologies (San Francisco) and participation from Cycle Capital Management (Quebec), Desjardins Innovatech (Quebec) and Closed Loop Capital (U.S.).

Publication date: 8/11/2017



Other news in this sector:

3/16/2018 Bioline expands Amblyseius andersoni line with new sachet format
3/15/2018 "Got aphids? Call in the reinforcements with banker plants"
3/15/2018 UK: New tool for powdery mildew control
3/14/2018 "Promising results in assessing new methods in IPM"
3/14/2018 Bayer publishes crop protection safety studies
3/13/2018 Italy: TYLCV variant risks damaging entire economy
3/13/2018 Spanish pepper grower successful with predatory mite
3/12/2018 Countries get heads up about leafminer invasion thanks to Virginia Tech
3/9/2018 Sri Lanka: Increased awareness about pest management and food safety
3/8/2018 Nufarm acquires Century portfolio from Syngenta and Adama
3/8/2018 Russia intercepts 250 kg of thrips-infected strawberries
3/7/2018 Protecting pollinators: What role can the greenhouse industry play?
3/6/2018 Philippines: Experts to increase plum tomato productivity
3/6/2018 Sclerotinia - an underestimated greenhouse disease
3/5/2018 BASF’s 2018 science competition focuses on plant stressors
3/5/2018 British-Chinese research unlocks strawberry disease resistance
3/5/2018 US (NH): Most prevalent weeds on New England's organic vegetable farms
3/1/2018 BASF expects to earn €3.5 billion with crop protection innovation
3/1/2018 UK: Stopping soil spread key to preventing lettuce Fusarium wilt
3/1/2018 UK: New priorities announced for plant protection research programme